Bio-Rad Laboratories BIO Clinical Diagnostics — Cost of goods sold

Other segment segments

Similar metrics at other companies

TEMDiagnostics — Cost of Goods Sold

$100.96M+19.1%

ABTDiagnostic Products — Cost of products sold, excluding amortization of intangible assets

$1.24B+7.8%

TEC

TECHDiagnostics And Spatial Biology — Cost of Goods Sold

$38.65M+3.9%

ABTDiagnostic Products — Selling, general, and administrative

$448M+14.3%

BIIBClinical Inventory — Cost of sales, excluding amortization and impairment of acquired intangible assets

$56.8M+851%

NTRAProduct revenues — Cost of revenues

$245.2M+32.8%

Questions, answered.

What is Bio-Rad Laboratories's clinical diagnostics — cost of goods sold?

Bio-Rad Laboratories (BIO) reported clinical diagnostics — cost of goods sold of $181.8M in Q1 2026.

How has Bio-Rad Laboratories's clinical diagnostics — cost of goods sold changed year-over-year?

Bio-Rad Laboratories's clinical diagnostics — cost of goods sold increased by 1.5% year-over-year, from $179.2M to $181.8M.

What is the long-term trend for Bio-Rad Laboratories's clinical diagnostics — cost of goods sold?

Over 3 years (2022 to 2025), Bio-Rad Laboratories's clinical diagnostics — cost of goods sold has grown at a 3.6% compound annual growth rate (CAGR), from $696.5M to $775.3M.

What does clinical diagnostics — cost of goods sold mean?

The direct costs attributable to the production and delivery of clinical diagnostic products, including raw materials, direct labor, and manufacturing overhead. It excludes operating expenses like R&D or SG&A.